Logo image of ANNA

ALEANNA INC (ANNA) Stock Fundamental Analysis

NASDAQ:ANNA - Nasdaq - US01444V1035 - Common Stock - Currency: USD

11.15  +0.36 (+3.34%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ANNA. ANNA was compared to 20 industry peers in the Independent Power and Renewable Electricity Producers industry. ANNA may be in some trouble as it scores bad on both profitability and health. ANNA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ANNA had negative earnings in the past year.
In the past year ANNA has reported a negative cash flow from operations.
ANNA Yearly Net Income VS EBIT VS OCF VS FCFANNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M -2M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.28%, ANNA is doing worse than 65.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of -0.40%, ANNA is in line with its industry, outperforming 45.00% of the companies in the same industry.
Industry RankSector Rank
ROA -0.28%
ROE -0.4%
ROIC N/A
ROA(3y)4.78%
ROA(5y)N/A
ROE(3y)5.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ANNA Yearly ROA, ROE, ROICANNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 5 -5 10 -10 15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ANNA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ANNA Yearly Profit, Operating, Gross MarginsANNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, ANNA has less shares outstanding
The debt/assets ratio for ANNA is higher compared to a year ago.
ANNA Yearly Shares OutstandingANNA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
ANNA Yearly Total Debt VS Total AssetsANNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

ANNA has an Altman-Z score of 100.61. This indicates that ANNA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 100.61, ANNA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ANNA has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ANNA (0.11) is better than 95.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 100.61
ROIC/WACCN/A
WACCN/A
ANNA Yearly LT Debt VS Equity VS FCFANNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

ANNA has a Current Ratio of 0.01. This is a bad value and indicates that ANNA is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.01, ANNA is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.01 indicates that ANNA may have some problems paying its short term obligations.
With a Quick ratio value of 0.01, ANNA is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
ANNA Yearly Current Assets VS Current LiabilitesANNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ANNA have decreased strongly by -110.29% in the last year.
EPS 1Y (TTM)-110.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-124.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ANNA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ANNA Price Earnings VS Forward Price EarningsANNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ANNA Per share dataANNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ANNA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALEANNA INC

NASDAQ:ANNA (5/2/2025, 1:12:15 PM)

11.15

+0.36 (+3.34%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners76.03%
Inst Owner Change0%
Ins Owners16.41%
Ins Owner Change-340.81%
Market Cap742.37M
AnalystsN/A
Price TargetN/A
Short Float %0.21%
Short Ratio3.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 78.11
P/tB 78.11
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.28%
ROE -0.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.78%
ROA(5y)N/A
ROE(3y)5.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 100.61
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-110.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-124.43%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y73.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.84%
OCF growth 3YN/A
OCF growth 5YN/A